Clinical Presentations

In this week's Homerun Slides, the vicious circle of hyperinsulinemia in patients with type 2 diabetes.

In this week's Homerun Slides, we begin a new series on the role of anti-diabetes medications in reducing cardiovascular risk and outcomes in diabetes patients.

In this week's Homerun Slides, the philosophy for the reduced need for insulin in type 2 patients and the potential benefits of combining GLP-1-based therapies with insulin.

In this week's Homerun Slides, the results of lowering plasma glucose concentration with dapagliflozin.

In this week's Homerun Slides, the addition of liraglutide to insulin degludec.

In this week's Homerun Slides, the study and results of the addition of insulin detemir to Liraglutide treatment of type 2 diabetes.

In this week's Homerun Slides, the effectiveness of Lixisenatide when added to basal insulin, and strategies for avoiding or minimizing the GI effects of GLP-1.

In this week's Homerun Slides, the results of a multinational, placebo-controlled, randomized, double-blind, parallel-group, 24-week study involving patients who were receiving insulin (not routine pre-meal short- or rapid-acting insulin, except as pre-mixed insulin) administered alone or in combination with metformin (³1500 mg per day) and who had inadequate glycemic control (A1C ³7.5% and ≤11%).

In this week's Homerun Slides, approaches to intensifying therapy in patients who are using basal insulin but are not yet at goal.

In this week's Homerun Slides, lessons from the ORIGIN Trial and insulin effects on human islet function.